Senior insider sale
PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$565.6K
62.15K shares
What this filing means
CESANO ALESSANDRA plans to sell 62.15K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $565.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/14/2026ACC: 0001959173-26-006918
Director
Since Jul 2022
62.15K
Shares to sell
$565.6K
Approx. market value
62.15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
9/14/2026
50KRestricted Stock Vesting
Compensation
6/11/2025
12.15KTotal acquired62.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/14/2026 | Stock Option Exercise Cash | 50K | — |
6/11/2025 | Restricted Stock Vesting Compensation | 12.15K | — |
| Total | 62.15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
62.15K
Market value
$565.6K
9/14/2026
Total
Units
62.15K
Value
$565.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/14/2026 | 62.15K | $565.6K | NASDAQ | Planned |
| Total | 62.15K | $565.6K | ||